Analysis identifies key metabolic abnormalities and hypoxia-related signaling pathways in type 1 diabetes patients, suggesting novel therapeutic targets.
Key Points
Significant metabolic abnormalities were observed in patients with type 1 diabetes mellitus, highlighting alterations in specific metabolites.
Differentially expressed genes were linked to important signaling pathways, including TGF-beta and MAPK pathways, suggesting potential targets for intervention.
Gene expression analysis revealed hub genes that connect various biological processes and metabolic changes in type 1 diabetes patients.
Findings may enhance our understanding of type 1 diabetes pathophysiology and provide insights into future treatment strategies.